Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
QuickView for WY 14,643 (compound)
Most Correlated Studies
- Hepatocytes treated with non-genotoxic carcinogens
- HepG2 cells treated with genotoxic and non-genotoxic agents
- Livers of CD-1 mice treated with genotoxic, non-genotoxic or non-hepatocarcinogens
- Primary hepatocytes treated with non-genotoxic carcinogens or non-carcinogens
- Embryonic stem cells treated with non-genotoxic carcinogens or non-carcinogens
Most Relevant Literature
- Chronic Treatment With WY-14643 Induces Tumorigenesis and Triglyceride Accumulation in Mouse Livers.
- PPARα agonist WY-14,643 enhances ethanol metabolism in mice: Role of catalase.
- PPARα Agonist WY-14643 Relieves Neuropathic Pain through SIRT1-Mediated Deacetylation of NF-κB.
- PPARα agonist WY-14,643 induces adipose atrophy and fails to blunt chronic ethanol-induced hepatic f…
- PPARα agonist WY-14,643 induces the PLA2/COX-2/ACOX1 pathway to enhance peroxisomal lipid metabolism…
